Patient 0 7 0 7 O
currently 8 17 8 17 O
has 18 21 18 21 O
unresolved 22 32 22 32 O
toxicities 33 43 33 43 O
for 44 47 44 47 O
which 48 53 48 53 O
ceritinib 54 63 54 63 B-treatment
dosing 64 70 64 70 O
has 71 74 71 74 O
been 75 79 75 79 O
interrupted 80 91 80 91 O
in 92 94 92 94 O
the 95 98 95 98 O
parent 99 105 99 105 O
study 106 111 106 111 O

Patient 0 7 112 119 O
has 8 11 120 123 O
been 12 16 124 128 O
permanently 17 28 129 140 O
and 29 32 141 144 O
prematurely 33 44 145 156 O
discontinued 45 57 157 169 O
from 58 62 170 174 O
ceritinib 63 72 175 184 B-treatment
study 73 78 185 190 O
treatment 79 88 191 200 O
in 89 91 201 203 O
the 92 95 204 207 O
parent 96 102 208 214 O
study 103 108 215 220 O
due 109 112 221 224 O
to 113 115 225 227 O
any 116 119 228 231 O
reason 120 126 232 238 O

Patient 0 7 239 246 O
is 8 10 247 249 O
currently 11 20 250 259 O
receiving 21 30 260 269 O
treatment 31 40 270 279 B-treatment
with 41 45 280 284 O
ceritinib 46 55 285 294 B-treatment
within 56 62 295 301 O
a 63 64 302 303 O
Novartis 65 73 304 312 O
- 73 74 312 313 O
sponsored 74 83 313 322 O
study 84 89 323 328 O
which 90 95 329 334 O
has 96 99 335 338 O
fulfilled 100 109 339 348 O
the 110 113 349 352 O
requirements 114 126 353 365 O
for 127 130 366 369 O
the 131 134 370 373 O
primary 135 142 374 381 O
objective 143 152 382 391 O
and 153 156 392 395 O
, 156 157 395 396 O
in 158 160 397 399 O
the 161 164 400 403 O
opinion 165 172 404 411 O
of 173 175 412 414 O
the 176 179 415 418 O
Investigator 180 192 419 431 O
, 192 193 431 432 O
would 194 199 433 438 O
benefit 200 207 439 446 O
from 208 212 447 451 O
continued 213 222 452 461 O
treatment 223 232 462 471 O

Pregnant 0 8 472 480 B-pregnancy
or 9 11 481 483 O
nursing 12 19 484 491 O
( 20 21 492 493 O
lactating 21 30 493 502 O
) 30 31 502 503 O
women 32 37 504 509 B-gender
, 37 38 509 510 O
where 39 44 511 516 O
pregnancy 45 54 517 526 B-pregnancy
is 55 57 527 529 O
defined 58 65 530 537 O
as 66 68 538 540 O
the 69 72 541 544 O
state 73 78 545 550 O
of 79 81 551 553 O
a 82 83 554 555 O
female 84 90 556 562 B-gender
after 91 96 563 568 O
conception 97 107 569 579 O
and 108 111 580 583 O
until 112 117 584 589 O
the 118 121 590 593 O
termination 122 133 594 605 O
of 134 136 606 608 O
gestation 137 146 609 618 O
, 146 147 618 619 O
confirmed 148 157 620 629 O
by 158 160 630 632 O
a 161 162 633 634 O
positive 163 171 635 643 O
serum 172 177 644 649 O
hCG 178 181 650 653 O
laboratory 182 192 654 664 O
test 193 197 665 669 O

Sexually 0 8 670 678 O
active 9 15 679 685 O
males 16 21 686 691 B-gender
unless 22 28 692 698 O
they 29 33 699 703 O
use 34 37 704 707 B-contraception_consent
a 38 39 708 709 I-contraception_consent
condom 40 46 710 716 I-contraception_consent
during 47 53 717 723 O
intercourse 54 65 724 735 O
while 66 71 736 741 O
taking 72 78 742 748 O
drug 79 83 749 753 O
and 84 87 754 757 O
for 88 91 758 761 O
3 92 93 762 763 O
months 94 100 764 770 O
after 101 106 771 776 O
stopping 107 115 777 785 O
ceritinib 116 125 786 795 B-treatment
and 126 129 796 799 O
should 130 136 800 806 O
not 137 140 807 810 O
father 141 147 811 817 O
a 148 149 818 819 O
child 150 155 820 825 O
for 156 159 826 829 O
at 160 162 830 832 O
least 163 168 833 838 O
3 169 170 839 840 O
months 171 177 841 847 O
after 178 183 848 853 O
the 184 187 854 857 O
last 188 192 858 862 O
dose 193 197 863 867 O
of 198 200 868 870 O
treatment 201 210 871 880 B-treatment

Women 0 5 881 886 B-gender
of 6 8 887 889 O
child 9 14 890 895 O
- 14 15 895 896 O
bearing 15 22 896 903 O
potential 23 32 904 913 O
, 32 33 913 914 O
defined 34 41 915 922 O
as 42 44 923 925 O
all 45 48 926 929 O
women 49 54 930 935 B-gender
physiologically 55 70 936 951 O
capable 71 78 952 959 B-pregnancy
of 79 81 960 962 I-pregnancy
becoming 82 90 963 971 I-pregnancy
pregnant 91 99 972 980 I-pregnancy
, 99 100 980 981 O
unless 101 107 982 988 O
they 108 112 989 993 O
are 113 116 994 997 O
using 117 122 998 1003 B-contraception_consent
highly 123 129 1004 1010 I-contraception_consent
effective 130 139 1011 1020 I-contraception_consent
methods 140 147 1021 1028 I-contraception_consent
of 148 150 1029 1031 I-contraception_consent
contraception 151 164 1032 1045 I-contraception_consent
during 165 171 1046 1052 O
dosing 172 178 1053 1059 O
and 179 182 1060 1063 O
for 183 186 1064 1067 O
3 187 188 1068 1069 B-upper_bound
months 189 195 1070 1076 I-upper_bound
afer 196 200 1077 1081 O
stopping 201 209 1082 1090 O
ceritinib 210 219 1091 1100 B-treatment
treatment 220 229 1101 1110 I-treatment

